Literature DB >> 8810350

Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE.

A T Pearman1, W Y Chou, K D Bergman, M R Pulumati, N C Partridge.   

Abstract

Many parathyroid hormone (PTH)-mediated events in osteoblasts are thought to require immediate early gene expression. PTH induces the immediate early gene, c-fos, in this cell type through a cAMP-dependent pathway. The present work investigated the nuclear mechanisms involved in PTH regulation of c-fos in the osteoblastic cell line, UMR 106-01. By transiently transfecting c-fos promoter 5' deletion constructs into UMR cells, we demonstrated that PTH induction of the c-fos promoter requires the major cAMP response element (CRE). Point mutations created in the major CRE within the largest construct inhibited both PTH-stimulated and basal expression. This element, therefore, performs concerted basal and PTH-responsive cis-acting functions. Gel retardation and Western blotting techniques revealed that CRE-binding protein (CREB) constitutively binds the major CRE but becomes phosphorylated at its cAMP-dependent protein kinase consensus recognition site following PTH treatment. CREB was functionally implicated in c-fos regulation by coexpressing a dominant CREB repressor, KCREB (killer CREB), with the c-fos promoter constructs. KCREB suppressed both basal and PTH-mediated c-fos induction. We conclude that PTH activates c-fos in osteoblasts through cAMP-dependent protein kinase-phosphorylated CREB interaction with the major CRE in the promoter region of the c-fos gene.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1996        PMID: 8810350     DOI: 10.1074/jbc.271.41.25715

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.

Authors:  Didier Merciris; Caroline Marty; Corinne Collet; Marie-Christine de Vernejoul; Valerie Geoffroy
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

2.  Essential role of RSK2 in c-Fos-dependent osteosarcoma development.

Authors:  Jean-Pierre David; Denis Mehic; Latifa Bakiri; Arndt F Schilling; Vice Mandic; Matthias Priemel; Maria Helena Idarraga; Markus O Reschke; Oskar Hoffmann; Michael Amling; Erwin F Wagner
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

3.  In vivo targeted deletion of calpain small subunit, Capn4, in cells of the osteoblast lineage impairs cell proliferation, differentiation, and bone formation.

Authors:  Masako Shimada; Peter A Greer; Andrew P McMahon; Mary L Bouxsein; Ernestina Schipani
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

Review 4.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

5.  The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass.

Authors:  Martin Pellicelli; Julie A Miller; Alice Arabian; Claude Gauthier; Omar Akhouayri; Joy Y Wu; Henry M Kronenberg; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

6.  Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways.

Authors:  Joy Y Wu; Louise E Purton; Stephen J Rodda; Min Chen; Lee S Weinstein; Andrew P McMahon; David T Scadden; Henry M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

7.  The central nervous system (CNS)-independent anti-bone-resorptive activity of muscle contraction and the underlying molecular and cellular signatures.

Authors:  Weiping Qin; Li Sun; Jay Cao; Yuanzhen Peng; Lauren Collier; Yong Wu; Graham Creasey; Jianhua Li; Yiwen Qin; Jonathan Jarvis; William A Bauman; Mone Zaidi; Christopher Cardozo
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

8.  Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.

Authors:  Partha Sinha; Piia Aarnisalo; Rhiannon Chubb; Ingrid J Poulton; Jun Guo; Gregory Nachtrab; Takaharu Kimura; Srilatha Swami; Hamid Saeed; Min Chen; Lee S Weinstein; Ernestina Schipani; Natalie A Sims; Henry M Kronenberg; Joy Y Wu
Journal:  J Biol Chem       Date:  2015-11-23       Impact factor: 5.157

9.  Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.

Authors:  Changjun Li; Qiujuan Xing; Bing Yu; Hui Xie; Weishan Wang; Chenhui Shi; Janet L Crane; Xu Cao; Mei Wan
Journal:  J Bone Miner Res       Date:  2013-10       Impact factor: 6.741

10.  Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone.

Authors:  Shibing Yu; Renny T Franceschi; Min Luo; Jie Fan; Di Jiang; Huiling Cao; Tae-Geon Kwon; Yumei Lai; Jian Zhang; Kenneth Patrene; Kurt Hankenson; G David Roodman; Guozhi Xiao
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.